Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Intra-Cellular Therapies Inc.
DescriptionActive metabolite of ITI-007, a dual serotonin (5-HT2A) receptor antagonist and dopamine receptor phosphoprotein modulator (DPPM)
Molecular Target Serotonin (5-HT2A) receptor ; Dopamine D2 receptor
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Neurology (unspecified)
Indication DetailsTreat mood disorders
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today